Maude L. Campbell

More than two-thirds of U.S. adults and one-third of children and adolescents are overweight or obese, according to the National Center for Health Statistics.

Each patient with a cardiometabolic disorder is likely to have an additional related disorder.

An estimated 47 million Americans have double the average risk of heart disease because they are affected by a complex constellation of interrelated conditions, including obesity, impaired glucose metabolism, hypertension, and lipid disorders.

The goal of seizure disorder management is to render the patient seizure-free without side effects.

This month's Clinical Centers of Excellence series features facilities offering comprehensive seizure disorder diagnosis and treatment augmented by active research protocols.

A 21-member International Expert Committee proposes that hemoglobin A1c (HbA1c) assays be the mainstay of type 2 diabetes screening and diagnosis, replacing fasting blood glucose (FBG) level and the oral glucose tolerance test (OGTT).

Researchers have identified a renin angiotensin system (RAS) genetic variant that independently predicts response to the angiotensin II receptor blocker (ARB) valsartan.

The much-anticipated results of the Rosiglitazone Evaluated for Cardiovascular Outcomes in Oral Agent Combination Therapy for Type 2 Diabetes (RECORD) trial seem destined to become yet another element in the agent's controversial history.